Notice of NIAID Participation in RFA-HL-26-018, Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

The reliability of biomedical research is foundational to public trust in science and to ensuring that findings can ultimately benefit patients and communities. NIH’s Gold Standard Science plan further advances this commitment by encouraging a culture that values replication and reproducibility, as well as promoting practices that strengthen confidence in scientific knowledge. In support of this p